Skip to main content
THAMES VENTURES VCT 2 PLC logo

THAMES VENTURES VCT 2 PLC — Investor Relations & Filings

Ticker · TV2H ISIN · GB00BWX53D91 LEI · 21380035MV1VRYEXPR95 IL Financial and insurance activities
Open in API
Filings indexed 200 across all filing types
Latest filing 2022-10-13 Regulatory Filings
Country GB United Kingdom
Listing IL TV2H

About THAMES VENTURES VCT 2 PLC

https://www.downing.co.uk/

Thames Ventures VCT 2 PLC is a venture capital trust (VCT) that invests in a portfolio of early-stage, unquoted UK companies. The trust's primary objective is to generate long-term capital growth for its shareholders. It focuses on investing in disruptive technology businesses and has also historically managed a dedicated share class for healthcare companies. The investment portfolio is composed of VCT-qualifying equity investments, supplemented by non-qualifying assets such as structured products and secured loans. The management of the VCT was acquired by Foresight Group in 2024.

Recent filings

Filing Released Lang Actions
Prospectus Registration Document
Regulatory Filings Classification · 96% confidence The document is titled a "Registration Document" and is dated October 13, 2022. It explicitly states it has been prepared in compliance with Regulation (EU) 2017/1129 (the UK Prospectus Regulation) and has been approved by the Financial Conduct Authority (FCA) as a simplified prospectus under Article 14. This structure, involving FCA approval for a document detailing company structure, risk factors, and investment portfolio analysis, is characteristic of a document used to register securities for public offering or listing, which aligns closely with the purpose of a Prospectus or similar offering document. While 'Prospectus' is not an explicit code, the content—detailed risk factors, corporate information, investment portfolio analysis, and compliance with prospectus regulations—strongly suggests a document related to raising capital or offering shares. Given the options, this document functions as a comprehensive disclosure document for investors, similar to what might precede a listing or major capital raise. Since it is a detailed registration document approved by the FCA, it is most closely related to the initial offering/disclosure documents. However, none of the codes perfectly match 'Prospectus' or 'Registration Document'. The document contains extensive financial and operational details, making it more than just an announcement (RPA/RNS). It is a foundational document. Given the context of VCTs and registration for public offering/listing compliance, it is a core regulatory disclosure. If we must choose from the list, and considering it is a comprehensive document detailing the structure and risks for potential investment, it is a foundational document. Since it is not a standard 10-K (Annual Report) or IR (Interim Report), and it is not a proxy statement (DEF 14A/PSI), the closest fit for a comprehensive, regulatory-mandated disclosure document detailing the structure and risks for investment purposes, especially one involving FCA approval under prospectus rules, is often categorized broadly or as a specific offering document. Since 'Prospectus' is missing, and this document is clearly designed to solicit investment by detailing the structure and risks, it is a core disclosure. In many databases, such registration documents are classified under general offering/disclosure categories. Given the detailed nature and regulatory compliance (Prospectus Regulation), it is a major disclosure. If we consider the possibility that this document is being filed in connection with a listing or offering, it is a primary disclosure document. Since there is no specific 'Prospectus' code, and it is not an earnings release, annual report, or interim report, I will classify it based on its function as a comprehensive disclosure document. If this document is being filed to comply with listing requirements or to offer shares, it is a major regulatory filing. Given the detailed nature and the fact that it is a 'Registration Document' approved by the FCA under Prospectus Regulation, it is a significant regulatory disclosure. I will select 'RNS' (Regulatory Filings) as the most appropriate fallback for a major, non-standard regulatory disclosure document that doesn't fit the specific financial report codes, although 'CAP' (Capital/Financing Update) is also plausible if this is tied to a specific fundraising round. However, 'Registration Document' implies a formal regulatory filing process. I will lean towards RNS as the best fit among the provided options for a comprehensive, non-periodic regulatory disclosure document. Revisiting the definitions: This document is a comprehensive disclosure document required by prospectus regulation, detailing risks, corporate structure, and investment strategy. It is not an ER, 10-K, or IR. It is not a simple announcement (RPA/RNS). It is a foundational document for investment. If this document is being used to solicit investment, it is a prospectus. Since 'Prospectus' is not an option, and it is a formal, FCA-approved document detailing the company for investment purposes, it is a major regulatory filing. I will stick with RNS as the best general regulatory filing category available, as it is a formal filing under UK Prospectus Regulation. Wait, the document is 141,848 characters long, so the 'MENU VS MEAL' rule does not apply. It is the report itself. Given the context of VCTs and the detailed nature, it is a foundational document for investment. If this were a US filing, it might be an S-1 or similar. Since it is a Registration Document under UK Prospectus Regulation, it is a primary disclosure. I will select RNS as the catch-all for major regulatory disclosures not covered elsewhere.
2022-10-13 English
Prospectus Healthcare Summary
Capital/Financing Update Classification · 98% confidence The document text explicitly states it is a 'prospectus dated 13 October 2022' issued by Thames Ventures VCT 2 plc, describing a 'public offer by the Company to raise up to £10 million'. It contains detailed historical financial tables (Balance Sheet, Income Statement, Cash Flow Statement) audited up to March 31, 2022, and discusses the structure of the offer and the issuer's VCT status. A prospectus detailing a public offer of securities is a primary document used for fundraising and capital structure changes. This aligns best with the 'Capital/Financing Update' category (CAP), as it is the document soliciting investment for a capital raise. It is not a standard Annual Report (10-K), Interim Report (IR), or Earnings Release (ER).
2022-10-13 English
Prospectus Healthcare Securities Notes
Capital/Financing Update Classification · 98% confidence The document is titled 'Healthcare Securities Note' and explicitly states it constitutes a 'securities note dated 13 October 2022' which, along with a Registration Document and a Summary, comprises a 'prospectus'. It details an 'Offer for Subscription' to raise capital (£10 million) and discusses the terms, risks, and application procedures for these new shares. This structure—a formal document offering securities for subscription, often involving a prospectus approved by the FCA—is characteristic of a document related to raising capital or financing activities, rather than a periodic financial report (like 10-K or IR) or a general announcement (like ER or RNS). The closest fit among the provided definitions is 'Capital/Financing Update' (CAP), as it is the primary document soliciting investment for the company's capital structure.
2022-10-13 English
Publication of Healthcare Prospectus
Capital/Financing Update Classification · 98% confidence The document is dated October 13, 2022, and is titled 'Publication of Healthcare Prospectus'. It details the issuance of a prospectus for subscription offers to raise capital (£10 million plus over-allotment) for 'Healthcare Shares'. This clearly relates to fundraising and capital structure changes. The document explicitly mentions the prospectus will be available via the National Storage Mechanism and provides links, but the core content is the announcement of the capital raising effort itself, not just the announcement of the report's availability. This fits the definition of Capital/Financing Update (CAP). It is not a full 10-K, an ER, or a simple RPA, as it contains substantive details about the financing terms, fees, and timeline.
2022-10-13 English
Portfolio Update and Net Asset Values
Net Asset Value Classification · 98% confidence The document explicitly states it contains 'Unaudited Portfolio Update Net Asset Values as at 31 August 2022' and provides a detailed 'UNAUDITED BALANCE SHEET' and 'UNAUDITED PORTFOLIO SUMMARIES' for various share classes, dated 12 October 2022. This content structure, focusing on the Net Asset Value (NAV) calculation and portfolio breakdown for an investment vehicle (VCT), directly matches the definition for Net Asset Value (NAV) updates, primarily used by investment funds.
2022-10-12 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is announcing 'Total Voting Rights' as of a specific date (30 September 2022) and references conformity with the 'Disclosure and Transparency Rule 5.6.1'. It details the number of shares in issue and the corresponding voting rights, which is information shareholders use to calculate notification thresholds under FCA rules. This content directly relates to changes in significant share ownership or voting power disclosure requirements, fitting the definition of Major Shareholding Notification (MRQ). Although it is a disclosure, it is not a general regulatory filing (RNS) or a report announcement (RPA), but a specific notification about voting rights denominator.
2022-09-30 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.